开发脑小血管疾病的治疗方法:对许可干预措施进行范围审查,以潜在的重新利用
Philip M Bath1,2, Elizabeth P Phan3, Gwynneth Clay1
1Stroke Trials Unit, University of Nottingham, Nottingham, England, NG7 2UH, UK.
F1000Research
|August 11, 2025
概括
这次审查确定了在脑小血管疾病 (cSVD) 试验中进行测试的甲福明,塔达拉菲尔和异索胺单酸盐. 这些获得许可的干预措施显示出对患有cSVD的患者进行重新定位的希望.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 大脑小血管疾病 (cSVD) 是一种进展性神经血管疾病,没有特定的治疗方法.
- cSVD有助于缺口中风,脑内出血和血管认知障碍 (VCI).
研究的目的:
- 确定在脑小血管疾病 (cSVD) 第三阶段试验中重新使用许可的干预措施.
主要方法:
- 进行了临床前和临床研究的快速,多阶段的范围审查.
- 干预措施被选,以英国的可用性和实用性进行过,并通过迷你元分析评估认知效应.
- 一个科学咨询小组对入围的干预措施进行了排名,以确定它们是否适用于cSVD试验.
主要成果:
- 最初的1757项干预名单被缩小到52项,然后减少到10项.
- 甲福明,塔达拉菲尔和异类固醇酸盐被确定为最适合在cSVD患者中立即进行第3期测试.
结论:
- 在cSVD中,有三种授权的干预措施 (metformin,tadalafil,isosorbide mononitrate) 适合进行第三期试验.
- 未来的审查可以通过自动化,文本挖掘和生成人工智能来增强,以管理大型数据集.
- 将数据驱动方法与机械方法相结合,可以进一步降低cSVD临床试验的风险.
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30